Cargando…

Comparative Effectiveness and Safety of Standard-Dose and Low-Dose Pembrolizumab in Patients with Non-Small-Cell Lung Cancer: A Multi-Institutional Cohort Study in Taiwan

SIMPLE SUMMARY: The comparative effectiveness and safety of the standard dose and lower doses of pembrolizumab in non-small-cell lung cancer (NSCLC) patients still remains limited. We conducted a retrospective multi-institutional cohort study of patients newly initiating pembrolizumab in Taiwan. We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Kai-Cheng, Shao, Shih-Chieh, Chen, Hui-Yu, Chan, Yuk-Ying, Fang, Yueh-Fu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909459/ https://www.ncbi.nlm.nih.gov/pubmed/35267465 http://dx.doi.org/10.3390/cancers14051157

Ejemplares similares

Pembrolizumab in advanced non-small cell lung cancer: safety implications of dose adjustments
por: Gower, Arjan, et al.
Publicado: (2022)

Low‐dose pembrolizumab in the treatment of advanced non‐small cell lung cancer
por: Low, Jia Li, et al.
Publicado: (2021)

Positive Predictive Value of ICD-10-CM Codes for Myocarditis in Claims Data: A Multi-Institutional Study in Taiwan
por: Wu, Li-Ying, et al.
Publicado: (2023)

Comparative effectiveness of dulaglutide versus liraglutide in Asian type 2 diabetes patients: a multi-institutional cohort study and meta-analysis
por: Chang, Kai-Cheng, et al.
Publicado: (2020)

Evaluation of dosing strategy for pembrolizumab for oncology indications
por: Freshwater, Tomoko, et al.
Publicado: (2017)

Single-Dose Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy
por: Beudel, Martijn, et al.
Publicado: (2021)

Standard-Dose Pembrolizumab Plus Alternate-Dose Ipilimumab in Advanced Melanoma: KEYNOTE-029 Cohort 1C, a Phase 2 Randomized Study of Two Dosing Schedules
por: Long, Georgina V., et al.
Publicado: (2021)

Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers
por: Baldini, Capucine, et al.
Publicado: (2022)

Multiple Autoimmune Complications After a Single Dose of Pembrolizumab
por: Ahdi, Hardeep S, et al.
Publicado: (2023)

Budget Impact Analysis of Fixed Dose Versus Weight-Based Dosing Regimen of Nivolumab and Pembrolizumab in the Treatment of Non-Small Cell Lung Cancer
por: Monirul, Sanjana, et al.
Publicado: (2020)

Comparative risk evaluation for cardiovascular events associated with dapagliflozin vs. empagliflozin in real-world type 2 diabetes patients: a multi-institutional cohort study
por: Shao, Shih-Chieh, et al.
Publicado: (2019)

Modified-Dose Pembrolizumab and Prognostic Outcomes among Non-Small Cell Lung Cancer Patients: A Chart Review Study
por: To, Sheng-Yin, et al.
Publicado: (2022)

An assessment of extended pembrolizumab dosing in advanced non-small-cell lung cancer in the COVID-19 pandemic
por: Moffat, Gordon Taylor, et al.
Publicado: (2023)

SUN-413 Dual Endocrinopathies Following Single Dose of Pembrolizumab Therapy
por: Parikh, Tanvi, et al.
Publicado: (2019)

Alternate Pembrolizumab Dosing Interval in Advanced NSCLC with PD-L1 TPS ≥ 50%: 3 Weekly Compared to 6 Weekly Dosing
por: Jones, Lauren, et al.
Publicado: (2022)

Effectiveness and safety of low-dose versus standard-dose rivaroxaban and apixaban in patients with atrial fibrillation
por: Perreault, Sylvie, et al.
Publicado: (2022)

Improved Consistency in Dosing Anti-Tuberculosis Drugs in Taipei, Taiwan
por: Chiang, Chen-Yuan, et al.
Publicado: (2012)

Correction: Improved Consistency in Dosing Anti-Tuberculosis Drugs in Taipei, Taiwan
por: Chiang, Chen-Yuan, et al.
Publicado: (2012)

Safety and antibody response of recipients who unexpectedly received undiluted prime dose of BNT162b2 COVID-19 vaccine in Taiwan
por: Sheng, Wang-Huei, et al.
Publicado: (2023)

Comparison of the efficacy and safety of intensive-dose and standard-dose statin treatment for stroke prevention: A meta-analysis
por: Wang, Juan, et al.
Publicado: (2016)

Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non–small-cell Lung Cancer
por: Sehgal, Kartik, et al.
Publicado: (2021)

Economics of alternative dosing strategies for pembrolizumab and nivolumab at a single academic cancer center
por: Hall, Evan, et al.
Publicado: (2020)

Cell-type specificity of lung cancer associated with low-dose soil heavy metal contamination in Taiwan: An ecological study
por: Huang, Hsien-Hung, et al.
Publicado: (2013)

Dose-response analysis of aripiprazole in patients with schizophrenia in Taiwan
por: Tien, Yun, et al.
Publicado: (2022)

Comparison of efficacy and safety between standard-dose and modified-dose FOLFIRINOX as a first-line treatment of pancreatic cancer
por: Kang, Huapyong, et al.
Publicado: (2018)

Safety and Effectiveness of Reduced Dose Versus Standard Dose Enoxaparin Venous Thromboembolism Prophylaxis in Underweight Medically Ill Patients
por: Nemeth, Abigail, et al.
Publicado: (2022)

Association Between Low-Dose Aspirin Use and Colorectal Cancer Incidence in Taiwan
por: Lin, Hui-Min Diana, et al.
Publicado: (2020)

Pembrolizumab Plus Amrubicin in Patients With Relapsed SCLC: Multi-Institutional, Single-Arm Phase 2 Study
por: Akamatsu, Hiroaki, et al.
Publicado: (2021)

Erythema Standard for Dose in Light
por: Mehta, P. M.
Publicado: (1941)

Guideline-Adherent Hypertension in Children and Adolescents: A Multi-Institutional Database Analysis from Taiwan
por: Chien, Shao-Ju, et al.
Publicado: (2023)

Strategies to maintain persistence of opioid agonist therapy during the novel coronavirus pandemic in Taiwan
por: Shih, Cheng-Chan, et al.
Publicado: (2020)

Efficacy and safety of PICOPREP tailored dosing compared with PICOPREP day-before dosing for colon cleansing: a multi-centric randomised study
por: Kiesslich, Ralf, et al.
Publicado: (2017)

Standardized Supportive Care Documentation Improves Safety of High‐Dose Methotrexate Treatment
por: Alsdorf, Winfried H., et al.
Publicado: (2020)

Safety and efficacy of low dose pioglitazone compared with standard dose pioglitazone in type 2 diabetes with chronic kidney disease: A randomized controlled trial
por: Satirapoj, Bancha, et al.
Publicado: (2018)

Bleeding and Thrombotic Risk in Low Dose Heparin Infusion as Compared to Standard Dose Heparin Infusion
por: Lutfi, Forat, et al.
Publicado: (2020)

High-Dose Osimertinib for CNS Progression in EGFR+ NSCLC: A Multi-Institutional Experience
por: Piper-Vallillo, A.J., et al.
Publicado: (2022)

A single dose of pembrolizumab treatment causing a profound and durable response in lung cancer
por: Kondo, Yoshihiro, et al.
Publicado: (2022)

582. Safety and Efficacy of High-Dose Ganciclovir versus Standard Dosing for Cytomegalovirus Viremia in Solid Organ Transplant (SOT) Recipients
por: Fitzmaurice, Mary Grace, et al.
Publicado: (2020)

Low-Dose NOACs Versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Asian Patients with NVAF: A Meta-Analysis
por: Li, Ze, et al.
Publicado: (2022)

Challenging the standard of care in advanced melanoma: focus on pembrolizumab
por: Abdul-Karim, Raghad M, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gfgcmt703o04d6ebf0jjai4pip